Enoximone
From Self-sufficiency
 | This article does not cite any references or sources. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. (October 2006) |
| File:Enoximone.svg | |
| Systematic (IUPAC) name | |
|---|---|
|
4-methyl-5-{[4-(methylsulfanyl)phenyl]carbonyl}-2,3-dihydro-1H-imidazol-2-one | |
| Clinical data | |
| Routes of administration | Intravenous |
| Legal status | |
| Legal status |
|
| Pharmacokinetic data | |
| Bioavailability | 50% (oral) |
| Protein binding | 85% |
| Metabolism | Hepatic oxidation |
| Biological half-life | 4 to 10 hours |
| Excretion | Renal (60 to 70%) |
| Identifiers | |
| CAS Number | 77671-31-9 |
| ATC code | C01CE03 (WHO) |
| PubChem | CID 53708 |
| Chemical data | |
| Formula | C12H12N2O2S |
| Molar mass | 248.302 g/mol[[Script error: No such module "String".]] |
| Script error: No such module "collapsible list". | |
| (verify) | |
Enoximone (INN, trade name Perfan) is an imidazole phosphodiesterase inhibitor. It is used in the treatment of congestive heart failure. Selective for phosphodiesterase 3
| 30px | This drug article relating to the cardiovascular system is a stub. You can help ssf by expanding it. |
Categories:
- Pages with script errors
- Articles lacking sources from October 2006
- Articles with invalid date parameter in template
- All articles lacking sources
- Pages with broken file links
- Infobox drug tracked parameters
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- 2Fix
- Cardiac stimulants
- Imidazoles
- Thioethers
- Ketones
- Ureas
- Lactams
- PDE3 inhibitors
- Cardiovascular system drug stubs
